Cargando…

Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R

Superparamagnetic iron oxide-based nanoparticles (SPIONs) are promising carriers as targeted drug delivery vehicles, because they can be guided to their target with the help of an external magnetic field. Functionalization of nanoparticles’ surface with molecules, which bind with high affinity to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Niescioruk, Anna, Nieciecka, Dorota, Puszko, Anna K., Królikowska, Agata, Kosson, Piotr, Perret, Gerard Y., Krysinski, Pawel, Misicka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406482/
https://www.ncbi.nlm.nih.gov/pubmed/28503085
http://dx.doi.org/10.1007/s11051-017-3859-x
_version_ 1783231961400082432
author Niescioruk, Anna
Nieciecka, Dorota
Puszko, Anna K.
Królikowska, Agata
Kosson, Piotr
Perret, Gerard Y.
Krysinski, Pawel
Misicka, Aleksandra
author_facet Niescioruk, Anna
Nieciecka, Dorota
Puszko, Anna K.
Królikowska, Agata
Kosson, Piotr
Perret, Gerard Y.
Krysinski, Pawel
Misicka, Aleksandra
author_sort Niescioruk, Anna
collection PubMed
description Superparamagnetic iron oxide-based nanoparticles (SPIONs) are promising carriers as targeted drug delivery vehicles, because they can be guided to their target with the help of an external magnetic field. Functionalization of nanoparticles’ surface with molecules, which bind with high affinity to receptors on target tissue significantly facilitates delivery of coated nanoparticles to their targeted site. Here, we demonstrate conjugation of an antiangiogenic and antitumor peptide ATWLPPR (A7R) to SPIONs modified with sebacic acid (SPIONs-SA). Successful conjugation was confirmed by various analytical techniques (FTIR, SERS, SEM-EDS, TEM, TGA). Cell cytotoxicity studies, against two cell lines (HUVEC and MDA-MB-231) indicated that SPIONs modified with A7R reduced HUVEC cell viability at concentrations higher than 0.01 mg Fe/mL, in comparison to cells that were exposed to either the nanoparticles modified with sebacic acid or A7R peptide solely, what might be partially caused by a process of internalization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11051-017-3859-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5406482
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-54064822017-05-12 Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R Niescioruk, Anna Nieciecka, Dorota Puszko, Anna K. Królikowska, Agata Kosson, Piotr Perret, Gerard Y. Krysinski, Pawel Misicka, Aleksandra J Nanopart Res Research Paper Superparamagnetic iron oxide-based nanoparticles (SPIONs) are promising carriers as targeted drug delivery vehicles, because they can be guided to their target with the help of an external magnetic field. Functionalization of nanoparticles’ surface with molecules, which bind with high affinity to receptors on target tissue significantly facilitates delivery of coated nanoparticles to their targeted site. Here, we demonstrate conjugation of an antiangiogenic and antitumor peptide ATWLPPR (A7R) to SPIONs modified with sebacic acid (SPIONs-SA). Successful conjugation was confirmed by various analytical techniques (FTIR, SERS, SEM-EDS, TEM, TGA). Cell cytotoxicity studies, against two cell lines (HUVEC and MDA-MB-231) indicated that SPIONs modified with A7R reduced HUVEC cell viability at concentrations higher than 0.01 mg Fe/mL, in comparison to cells that were exposed to either the nanoparticles modified with sebacic acid or A7R peptide solely, what might be partially caused by a process of internalization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11051-017-3859-x) contains supplementary material, which is available to authorized users. Springer Netherlands 2017-04-26 2017 /pmc/articles/PMC5406482/ /pubmed/28503085 http://dx.doi.org/10.1007/s11051-017-3859-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Paper
Niescioruk, Anna
Nieciecka, Dorota
Puszko, Anna K.
Królikowska, Agata
Kosson, Piotr
Perret, Gerard Y.
Krysinski, Pawel
Misicka, Aleksandra
Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title_full Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title_fullStr Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title_full_unstemmed Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title_short Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
title_sort physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide a7r
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406482/
https://www.ncbi.nlm.nih.gov/pubmed/28503085
http://dx.doi.org/10.1007/s11051-017-3859-x
work_keys_str_mv AT niesciorukanna physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT niecieckadorota physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT puszkoannak physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT krolikowskaagata physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT kossonpiotr physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT perretgerardy physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT krysinskipawel physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r
AT misickaaleksandra physicochemicalpropertiesandinvitrocytotoxicityofironoxidebasednanoparticlesmodifiedwithantiangiogenicandantitumorpeptidea7r